UTI BSE Low Volatility Index Fund

A Equity Funds scheme from UTI Mutual Fund. Figures below are for the Direct · Growth plan (ISIN INF789F1AVF2).

NAV ₹16.0261 on 16 November 2026.

Expense ratio

Total expense ratio 0.66% a year for the Direct · Growth plan, as AMFI published it on 29 October 2026: base expense ratio 0.40%, brokerage 0.01%, transaction costs 0.00%, statutory levies including GST 0.25%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino
1 year-8.5%12.3%-15.8%-1.26-1.16
3 years6.7%11.5%-18.6%-0.03-0.02

Too little NAV history for the 5, 10-year figures.

Not ranked in its category: its category mixes funds too different to rank against one another.

Largest holdings

Top 10 (September 2026 disclosure). Company shares make up 95.2% of the portfolio.

  1. Castrol India Limited — 4.94%
  2. REIT- MINDSPACE BUSINESS PARKS (REIT units) — 4.47%
  3. Marico Limited — 3.65%
  4. Abbott India Limited — 3.62%
  5. Apollo Hospitals Enterprise Limited — 3.48%
  6. ITC Limited — 3.47%
  7. Sun Pharmaceutical Industries Limited — 3.45%
  8. Bharti Airtel Limited — 3.42%
  9. NTPC Limited — 3.42%
  10. SBI Life Insurance Company Limited — 3.41%

Plans

Other funds in Equity Funds

All 88 funds in Equity Funds · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.